Karen Vousden
What turned you on to biology in the fi rst place? Biology and Chemistry A levels in my high school were taught in a very hands-on experimental style and I loved the problem-solving aspect. I was actually better at maths back then but found the idea that we could understand the mystery of life too fascinating to ignore. I also grew up with Jacques Cousteau on the TV and was tempted to explore the oceans -I even had an offer to study Marine Biology at Bangor University. But I also had a boyfriend at home so chose to stay close and go to a London university. Not a very noble reason for the choice, and of course I broke up with the boyfriend within weeks of starting university, but it all worked out well in the end.
And what drew you to your specifi c fi eld of research? I was trained as a classical geneticist. My PhD work used a basidiomycete fungus as a model -I was mapping genes back in the days before sequencing. I enjoyed the work, but when I was scanning the back of Nature for postdoc options I came across an advert from Chris Marshall, who had just moved to the Institute of Cancer Research in London. Although I knew very little about cancer or mammalian biology in general, it sounded fascinating and I applied. After interviewing with Chris, there was no question that working with him was what I wanted to do. These were such exciting times for cancer research -human oncogenes were being discovered and the fi eld was moving very fast. I was very lucky to be part of it.
Who were your key early infl uences? One of my fi rst infl uences was my Chemistry teacher at high school -the archetypal mad scientist who made experimentation fun. He had great faith in me and told me that the sky's the limit -a statement that really stuck with me. Another important infl uence was my PhD supervisor, Lorna Casselton. Lorna was a superb scientist who taught me all about doing experiments right. She also spent a lot of time with collaborators in Brazil, and this made me realise that doing science could open the world beyond just being in a lab in London. She was also absolutely no-nonsense: if I ever voiced any doubts, she would simply tell me not to be ridiculous. Exactly what I needed. And of course she was a fabulous example of an outstanding woman in science. Then, the small team that I joined at the Institute of Cancer Research really opened my eyes to how much fun and how exciting science could be. Working with Chris Marshall and Alan Hall was a privilege that I simply fell into. Chris was a real inspiration and he taught me that science is a life passion, not simply a job. I can't imagine anything worse than doing a job you don't enjoy and not looking forward to going to work in the morning. During this time, I also met some wonderful people, many of whom are still close friends today. This is another aspect of science that I love: the brilliant, humorous and sometimes totally wacky people that surround you. Despite all the competition, I am always amazed at how kind and generous the vast majority of scientists are.
What is the best advice you've been given? At high school, my careers advisor told me to give up the idea of doing research -it was much too diffi cult -and work in a bank instead. I probably would have been much richer if I had followed that advice, but it annoyed me so much that I became even more determined to follow my own path. I suppose that refusing to be deterred is a useful characteristic in this career. I have also been lucky in the people I have worked with and who
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Current Biology 28, R761-R783, July 23, 2018 R769 have looked after me -Chris Marshall, Doug Lowy and George Vande Woude. Each one helped and encouraged me, and showed me by example what makes an outstanding scientist. They also gave me opportunities to stretch myself, maybe more than I deserved. In addition to providing advice and setting an example, they gave me confi dence to accept challenges and take the most exciting road. It is so important to fi nd someone who has faith in you; it's very easy for us to get discouraged and then convince ourselves we are just not good enough. A mentor who will both push you and watch out for you is key.
What led you to take up the various positions throughout your career? I always accepted jobs that seemed exciting to me, and I rarely took the most sensible option. Although I generally worry about everything, when it came to my career, I really didn't stress too much -I always felt confi dent that something would turn up. When I moved to take up my fi rst independent position at the Ludwig Institute in London, I also had another offer in a very well-known lab in a big and established institute in the UK. That would have been the sensible option but running my own lab seemed like much more fun, so I did that. The move back to the US and then to the Beatson Institute in Glasgow were each decisions that were made based on how challenging and exciting the opportunity seemed. Safety never really came into it. My poor family had to trail around the world after me, but I haven't regretted a single move. Being a research scientist can be hard and demoralising work, so keeping the fun, excitement and passion alive is critical. It worries me to see so many young people limiting their options because they are too timid to make a big move. My advice is to make career choices with the heart, not the head, and to be bold.
If you had not made it as a scientist, what would you have become?
My parents wanted me to be a hairdresser but, given my lack of dexterity, I think that would have been a very bad idea. I believe I would have made a decent architect: I've been involved in designing a couple of lab buildings and the house we built during our time in the US. I think I have a good feeling for how spaces work together and my efforts seemed to turn out well, so it's something I would have enjoyed.
What's your favourite experiment?
The best experiments are those that produce weird results that turn out to be true. When Michael Kubbutat was using co-transfection to explore how MDM2 could regulate p53, he consistently found that, when he added MDM2, the p53 protein disappeared. He thought he might have been doing something wrong, but of course it turned out that MDM2 is a ubiquitin ligase that targets p53 for degradation. Doug Lowy once told me that you should always believe in your results, even when they are not telling you what you expected. Results that destroy your model are often the best.
What is your greatest research ambition? One obvious ambition is to see some of my research translate into helping patients with cancer. Cancer research is such a large global effort that it's sometimes diffi cult to pinpoint just one key contribution, but it is important to be part of the development of something useful. I've also noticed that, whenever I set a goal and reach it, there is always another one -more enticing -just ahead. So maybe another research ambition is never to reach my goal -I always want there to be another mountain to climb. I would hate to feel that I am done. Do you feel a push towards more applied science? How does that affect your own work? I've spent most of my career working in cancer research, so it's very natural for me to want to see my work applied. I enjoy the discovery aspect of what I do, but to see work to which I have contributed being developed into something that enters clinical practice is satisfying beyond words. While I was with Doug Lowy at the NCI, I made the tiniest of contributions towards understanding that human papillomaviruses can cause cancer. Now my daughter and her friends have been vaccinated against these high-risk HPVs and, I believe, will be protected from developing cervical cancer. While my contribution to this was miniscule, it still feels really good to have been part of the story. Do you believe there is a need for more crosstalk between biological disciplines? I think crosstalk between all scientifi c disciplines can lead to some of the most innovative and exciting advances, but it needs to be driven by scientifi c curiosity, not through top-down edicts. Although ring-fenced funding for such initiatives always helps, of course! Do you think there is too much emphasis on big data-gathering collaborations as opposed to hypothesis-driven research by small groups? I enjoy doing hypothesis-driven R770 Current Biology 28, R761-R783, July 23, 2018 © 2018 Elsevier Ltd. research; it's what excites me about science and I think gives me a level of satisfaction that the more data-gathering projects wouldn't do. But that's just me, and I think all these approaches are important and valid. I wouldn't like the more focused, hypothesis-driven work to be abandoned for 'big data' studies and I do worry a bit that it is easier in datagathering studies to develop and tick off the kinds of milestones that can be used as a proxy for success. So we need to be very careful that we understand and assess the value of all research and fund accordingly. Having said that, I am very excited by some of the insights that are beginning to emerge from the 'big data' projects, and so maybe I'll be converted to work on them at some point too.
Which aspect of science, your fi eld or in general, do you wish the general public knew more about? I wish the general public knew more about all aspects of science and felt more comfortable with it. There are some outstanding programmes for TV and radio, but I wonder whether they are really reaching most people, or just playing to the converted. It would be great if science was integrated into soap operas in a way that made it seem normal to be a scientist or be interested in science -much more part of everyday life. I always enjoy giving lay talks or communicating with the public. Generally, I get comments about how amazing it is that I am quite 'normal'. I think this is a compliment, but it does tell us that people in general think scientists are weird creatures who it's generally best to avoid. It would be good to break that down a bit.
Another issue that concerns me is the huge amount of misinformation that is in the press, especially about health issues. Almost every day we see another article about something that will cause cancer -toast, coffee, sausages. The problem is that people become immune to guidance on health matters and then don't pay attention to well-founded advice, such as to stop smoking and lose weight. It's a shame because I think it's important for people to trust and believe scientists -otherwise, what's the point of us?
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What is Toxoplasma gondii?
Toxoplasma gondii is an obligate intracellular protozoan parasite, which means that T. gondii is a unicellular eukaryote that survives by living in host cells. T. gondii is in the Apicomplexa family, which includes other protozoans such as Plasmodium species, the causative agents of malaria, and Cryptosporidium, a common cause of childhood diarrheal illnesses. All Apicomplexa have unique organelles at one end of the cell -the apical end -that are used for host cell invasion. Some Apicomplexa, such as T. gondii and the Plasmodium species, also have an apicoplast -a unique algae-derived organelle that is dedicated to specifi c metabolic functions, such as fatty-acid synthesis.
What sort of life cycle does T. gondii have? T. gondii's life cycle has both sexual and asexual phases. The sexual life cycle only occurs in cats, which are therefore referred to as the 'defi nitive' hosts for T. gondii. In the cat gut epithelium, T. gondii differentiates into male and female gametocytes allowing sexual reproduction (thus, in a cat infected with two strains of T. gondii, genetic recombination can occur). Ultimately, cats with primary infections can shed millions of oocytes, which contain four haploid sporozoites. We do not yet know what makes the cat gut epithelium so special but methods for culturing cat gut epithelium in a lab are being developed and may enable researchers to address this question.
In addition to its defi nitive host, T. gondii can naturally infect a wide range of warm-blooded intermediate hosts, ranging from birds to humans to rodents. In intermediate hosts, T. gondii undergoes asexual replication, meaning that parasites simply replicate their haploid genome and divide into two daughter cells. This process is known as endodyogeny and is slightly different from typical eukaryotic cell division. In endodyogeny, two daughter cells form within the mother cell, which eventually
